Talk to us about..
Diagnostics, Microbiome Profiling, Microbiome Analysis, Prognostics, Precision Medicine, Stratification of patients, IBD, IBS, Immune Checkpoint Inhibitors, Immune Oncology, Colorectal cancer
View our sessions
Name
INTERACTIVE PANEL DISCUSSION: Microbiome Investment
Date & Time
Wednesday, June 3, 2020, 9:25 AM - 10:00 AM
Name
From Lab Bench to Bedside: Positioning Microbiome Analysis for Clinical Utility
Date & Time
Wednesday, June 3, 2020, 11:50 AM - 12:15 PM
Speakers
Description
• PMP is a rapid, detailed, accurate and high throughput microbiome profiling tool that makes that fulfills the requirements for microbiome-based Precision Medicine in a clinical setting.
• Learn about preliminary results of using PMP to distinguish between UC and CD in children with IBD.
• Application of PMP in cancer treatment in general and ImmuneOncology specifically.
Session Type
Presentation
Virtual Session Link
On Demand
https://vimeo.com/426992288/699c396e07
Description
Bio-Me is transforming microbiome analysis by making it possible to analyze hundreds of samples in less than a day, with high resolution and reproducibility and at an affordable cost. Combined with an exclusive biobank and extensive patient database, Bio-Me’s Precision Microbiome Profiling platform (PMP) will enable microbiome-based Companion Diagnostics and discovery of novel drug targets to improve health and well-being worldwide.
Bio-Me offers a range of proprietary solutions to support research and development of microbiome-based information.
The PMP platform technology combined with access to world-leading BioBanks opens up for many exciting microbiome-based clinical applications.
Bio-Me offers a range of proprietary solutions to support research and development of microbiome-based information.
The PMP platform technology combined with access to world-leading BioBanks opens up for many exciting microbiome-based clinical applications.
Website
Useful Resources